NCT05070819View on ClinicalTrials.gov

Atrial Natriuretic Peptide in Assessing Fluid Status

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

March 28, 2022

Study Completion Date

April 7, 2022

Conditions
Fluid OverloadFluid LossVolume OverloadCardiac DiseaseCardiac Output, LowCardiac Output, High
Interventions
DIAGNOSTIC_TEST

pro-ANP

pro-ANP samples and fluid status assessment with functional tests (Teboul test) will be used 8 times intraoperatively.

Trial Locations (1)

119991

Petrovsky Research National Centre of Surgery (Petrovsky NRCS), Moscow

All Listed Sponsors
lead

Petrovsky National Research Centre of Surgery

OTHER

NCT05070819 - Atrial Natriuretic Peptide in Assessing Fluid Status | Biotech Hunter | Biotech Hunter